Acta Pharmacologica Sinica

4.0k papers and 114.2k indexed citations i.

About

The 4.0k papers published in Acta Pharmacologica Sinica in the last decades have received a total of 114.2k indexed citations. Papers published in Acta Pharmacologica Sinica usually cover Molecular Biology (2.2k papers), Oncology (548 papers) and Cellular and Molecular Neuroscience (446 papers) specifically the topics of Receptor Mechanisms and Signaling (202 papers), Neuroscience and Neuropharmacology Research (200 papers) and Ion channel regulation and function (188 papers). The most active scholars publishing in Acta Pharmacologica Sinica are Zheng‐Hong Qin, Hualiang Jiang, Guangji Wang, Nai‐Hong Chen and Jian Ding.

In The Last Decade

Fields of papers published in Acta Pharmacologica Sinica

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Acta Pharmacologica Sinica. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Acta Pharmacologica Sinica

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Acta Pharmacologica Sinica. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Acta Pharmacologica Sinica with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025